Niagen Bioscience Income Statement (2010-2026) | NAGE

1Y3Y5Y7Y10YAll
Download Data
Income Statement Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Mar2014 Jun2014 Sep2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Dec2016 Apr2017 Jul2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
17.70M17.31M17.76M17.26M16.73M17.06M21.00M22.56M20.32M19.50M21.20M22.15M22.74M25.58M29.12M30.48M31.12M33.99M33.84M31.47M
Cost of Revenue (Quarter)
6.23M6.73M6.89M8.24M6.69M6.86M7.13M7.87M7.97M7.53M1.91M6.74M9.05M7.04M2.39M11.15M8.21M8.77M21.14M3.52M
Gross Profit (Quarter)
10.81M10.58M10.87M10.53M10.04M10.21M12.02M13.52M12.36M11.97M12.94M13.46M13.69M16.24M18.20M19.33M20.23M21.93M21.70M19.98M
Operating items
Research & Development (Quarter)
1.00M1.00M1.04M1.08M1.25M1.22M1.28M1.19M1.36M1.24M1.16M2.10M1.32M1.29M1.31M1.26M1.57M1.79M1.71M1.48M
Selling, General & Administrative (Quarter)
9.13M11.20M6.50M8.95M7.16M6.18M5.99M6.42M7.30M5.84M5.43M5.35M5.66M6.30M1.05M5.18M7.27M7.13M7.48M7.24M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)
6.23M7.22M8.64M8.24M8.02M5.87M6.19M7.87M6.01M6.04M6.52M6.74M6.97M7.04M8.72M8.21M8.77M8.43M4.78M
Operating Expenses (Quarter)
16.36M19.42M16.18M18.26M16.43M13.27M13.46M15.49M14.67M13.12M13.11M14.19M13.95M14.64M11.09M14.56M17.04M17.69M17.62M18.40M
Operating Income (Quarter)
-5.55M-8.84M-5.32M-7.73M-6.39M-3.06M-1.44M-1.97M-2.32M-1.15M-0.17M-0.73M-0.26M1.60M7.11M4.77M3.19M4.24M4.09M1.58M
EBIT (Quarter)
-5.55M-8.84M-5.32M-7.73M-6.39M-3.06M-1.44M-1.97M-2.32M-1.15M-0.17M-0.73M-0.26M1.60M7.11M4.77M3.19M4.24M4.09M1.58M
Non-operating items
Interest & Investment Income (Quarter)
0.12M0.19M0.28M0.24M0.24M0.28M0.37M0.46M0.55M0.56M0.55M0.38M
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)
Net income details
EBT (Quarter)
-5.57M-8.86M-5.33M-7.74M-6.40M-3.07M-1.44M-1.97M-2.19M-0.96M0.11M-0.49M-0.01M1.88M7.48M5.23M3.74M4.80M4.42M6.74M
Tax Provisions (Quarter)
0.30M0.17M0.13M0.22M0.29M0.42M
Profit After Tax (Quarter)
-5.57M-8.86M-5.33M-7.74M-6.40M-0.98M-1.42M-1.90M-2.19M-0.96M0.11M-0.49M-0.01M1.88M7.18M5.06M3.61M4.58M4.08M6.32M
Income from Continuing Operations (Quarter)
-5.57M-8.86M-5.33M-7.74M-6.40M-3.07M-1.44M-1.97M-2.19M-0.96M0.11M-0.49M-0.01M1.88M7.18M5.06M3.61M4.58M4.13M6.32M
Consolidated Net Income (Quarter)
-5.57M-8.86M-5.33M-7.74M-6.40M-3.07M-1.44M-1.97M-2.19M-0.96M0.11M-0.49M-0.01M1.88M7.18M5.06M3.61M4.58M4.13M6.32M
Income towards Parent Company (Quarter)
-5.57M-8.86M-5.33M-7.74M-6.40M-3.07M-1.44M-1.97M-2.19M-0.96M0.11M-0.49M-0.01M1.88M7.18M5.06M3.61M4.58M4.13M6.32M
Net Income towards Common Stockholders (Quarter)
-5.57M-8.86M-5.33M-7.74M-6.40M-3.07M-1.44M-1.97M-2.19M-0.96M0.11M-0.49M-0.01M1.88M7.18M5.06M3.61M4.58M4.13M6.32M
Additional items
EPS (Basic) (Quarter)
-0.08-0.13-0.07-0.11-0.09-0.01-0.02-0.03-0.03-0.010.00-0.010.000.020.090.070.050.060.050.08
EPS (Weighted Average and Diluted) (Quarter)
-0.08-0.13-0.07-0.11-0.09-0.01-0.02-0.03-0.03-0.010.00-0.010.000.020.090.060.040.050.050.07
Shares Outstanding (Weighted Average) (Quarter)
66.09M66.81M67.19M68.31M68.33M68.34M69.73M74.80M74.88M74.94M74.98M75.23M75.56M75.97M75.93M77.81M79.25M78.95M79.18M79.92M
Shares Outstanding (Diluted Average) (Quarter)
67.99M68.24M67.19M68.31M68.34M68.34M69.73M74.80M74.97M75.05M74.98M75.23M75.56M77.77M78.12M83.23M86.24M85.49M85.44M84.57M
EBITDA (Quarter)
-5.55M-8.84M-5.32M-7.73M-6.39M-3.06M-1.44M-1.97M-2.32M-1.15M-0.17M-0.73M-0.26M1.60M7.11M4.77M3.19M4.24M4.09M1.58M
Interest Expenses (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M
Tax Rate (Quarter)
4.08%3.21%3.43%4.63%6.60%6.19%